A
Agnieszka Czarniecka
Researcher at Curie Institute
Publications - 75
Citations - 3114
Agnieszka Czarniecka is an academic researcher from Curie Institute. The author has contributed to research in topics: Papillary thyroid cancer & Thyroid cancer. The author has an hindex of 21, co-authored 66 publications receiving 2506 citations. Previous affiliations of Agnieszka Czarniecka include University of Pittsburgh & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer
Michael Mingzhao Xing,Ali S. Alzahrani,Kathryn A. Carson,David Viola,Rossella Elisei,Bela Bendlova,Linwah Yip,Caterina Mian,Federica Vianello,R. Michael Tuttle,Eyal Robenshtok,James A. Fagin,Efisio Puxeddu,Laura Fugazzola,Agnieszka Czarniecka,Barbara Jarzab,Christine J. O'Neill,Mark Sywak,Alfred King-Yin Lam,Garcilaso Riesco-Eizaguirre,Garcilaso Riesco-Eizaguirre,Pilar Santisteban,Hirotaka Nakayama,Ralph P. Tufano,Sara I. Pai,Martha A. Zeiger,William H. Westra,Douglas P. Clark,Roderick J. Clifton-Bligh,David Sidransky,Paul W. Ladenson,Vlasta Sykorova +31 more
TL;DR: In this retrospective multicenter study, the presence of the BRAF V600E mutation was significantly associated with increased cancer-related mortality among patients with PTC, and the association was not independent of tumor features.
Journal ArticleDOI
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Mingzhao Xing,Ali S. Alzahrani,Kathryn A. Carson,Young Kee Shong,Tae Yong Kim,David Viola,Rossella Elisei,Bela Bendlova,Linwah Yip,Caterina Mian,Federica Vianello,R. Michael Tuttle,Eyal Robenshtok,James A. Fagin,Efisio Puxeddu,Laura Fugazzola,Agnieszka Czarniecka,Barbara Jarzab,Christine J. O'Neill,Mark Sywak,Alfred King-Yin Lam,Garcilaso Riesco-Eizaguirre,Pilar Santisteban,Hirotaka Nakayama,Roderick J. Clifton-Bligh,Giovanni Tallini,Elizabeth H. Holt,Vlasta Sýkorová +27 more
TL;DR: BRAF mutation was associated with poorer recurrence-free probability in Kaplan-Meier survival analyses in various clinicopathologic categories and demonstrated an independent prognostic value of BRAF V600E mutation for PTC recurrence in various clinical categories.
Journal ArticleDOI
Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
Barbara Jarząb,Malgorzata Wiench,Krzysztof Fujarewicz,Krzysztof Simek,Michał Jarząb,Malgorzata Oczko-Wojciechowska,Jan Włoch,Agnieszka Czarniecka,Ewa Chmielik,Dariusz Lange,Agnieszka Pawlaczek,Sylwia Szpak,Elzbieta Gubala,Andrzej Świerniak +13 more
TL;DR: The results prove that the gene expression signal of PTC is easily detectable even when cancer cells do not prevail over tumor stroma and propose a potent molecular classifier able to discriminate between PTC and nonmalignant thyroid in more than 90% of investigated samples.
Journal ArticleDOI
Correction: Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
Malgorzata Oczko-Wojciechowska,Michal Swierniak,Jolanta Krajewska,Małgorzata Kowalska,Monika Kowal,Tomasz Stokowy,Bartosz Wojtas,Dagmara Rusinek,Agnieszka Pawlaczek,Agnieszka Czarniecka,Sylwia Szpak-Ulczok,Tomasz Gawlik,Ewa Chmielik,Tomasz Tyszkiewicz,Barbara Nikiel,Dariusz Lange,Michal Jarzab,Malgorzata Wiench,Barbara Jarzab +18 more
TL;DR: In this Article, an affiliation for Bartosz Wojtas was omitted and the correct affiliations are listed below: Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of On cancerology, Gliwice Branch, Poland.
Journal ArticleDOI
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Xiaoguang Shi,Rengyun Liu,Fulvio Basolo,Riccardo Giannini,Xiaopei Shen,Di Teng,Haixia Guan,Zhongyan Shan,Weiping Teng,Thomas J. Musholt,Khawla S. Al-Kuraya,Laura Fugazzola,Carla Colombo,Electron Kebebew,Barbara Jarzab,Agnieszka Czarniecka,Bela Bendlova,Vlasta Sykorova,Manuel Sobrinho-Simões,Paula Soares,Young Kee Shong,Tae Yong Kim,Sonia Cheng,Sylvia L. Asa,David Viola,Rossella Elisei,Linwah Yip,Caterina Mian,Federica Vianello,Yangang Wang,Shihua Zhao,Gisele Oler,Janete M. Cerutti,Efisio Puxeddu,Shen Qu,Qing Wei,Huixiong Xu,Christine J. O'Neill,Mark Sywak,Roderick J. Clifton-Bligh,Alfred King-Yin Lam,Garcilaso Riesco-Eizaguirre,Pilar Santisteban,Hongyu Yu,Giovanni Tallini,Elizabeth H. Holt,Vasily Vasko,Mingzhao Xing +47 more
TL;DR: This large multicenter study demonstrates differential prognostic risks of the three major PTC variants and establishes a unique risk order of TCPTC > CPTC ≫ FVPTC, providing important clinical implications for specific variant-based management of PTC.